Interplay between human islet amyloid polypeptide aggregates and micro-heterogeneous membranes

Biochim Biophys Acta Biomembr. 2021 Nov 1;1863(11):183691. doi: 10.1016/j.bbamem.2021.183691. Epub 2021 Jul 2.

Abstract

Human islet amyloid polypeptides (hIAPP) aggregate into amyloid deposits in the pancreatic islets of Langerhans, contributing to the loss of β-cells of patients with type 2 diabetes. Despite extensive studies of membrane disruption associated with hIAPP aggregates, the molecular details regarding the complex interplay between hIAPP aggregates and raft-containing membranes are still very limited. Using all-atom molecular dynamics simulations, we investigate the impact of hIAPP aggregate insertion on lipid segregation. We have found that the domain separation of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) is enhanced upon hIAPP membrane permeabilization in the absence of cholesterol, while within our simulation timescale, we cannot provide definitive evidence regarding the impact of hIAPP insertion on domain segregation in the ternary mixture (DOPC/DPPC/cholesterol). When the lipid domains are perturbed, their restoration occurs rapidly and spontaneously in the presence of hIAPP aggregates. hIAPP insertion affects membrane thickness in its immediate surroundings. On average, hIAPP causes the fluidity of lipids to increase and even cholesterol shows enhanced diffusivity. The acyl chain packing of the lipids near hIAPP is disrupted as compared to that further away from it. Cholesterol not only modulates membrane mobility and ordering but also hIAPP aggregates' structure and relative orientation to the membrane. Our investigations on the interaction between hIAPP aggregates and raft-containing membranes could lead to a better understanding of the mechanisms of amyloid cytotoxicity.

Keywords: Cholesterol; Islet amyloid polypeptide; Lipid domain; Membrane disruption; Molecular dynamics simulation; Oligomer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopolymers / metabolism
  • Cholesterol / metabolism
  • Humans
  • Islet Amyloid Polypeptide / chemistry
  • Islet Amyloid Polypeptide / metabolism*
  • Membrane Fluidity
  • Membrane Lipids / metabolism
  • Membrane Microdomains / metabolism*
  • Microscopy, Atomic Force
  • Molecular Dynamics Simulation
  • Protein Conformation, beta-Strand

Substances

  • Biopolymers
  • Islet Amyloid Polypeptide
  • Membrane Lipids
  • Cholesterol